Monograph
J07CA02 - Diphtheria-Pertussis-Poliomyelitis-Tetanus |
Propably not porphyrinogenic |
PNP |
Rationale
Based on the pharmacokinetics of the diphtheria-pertussis-poliomyelitis-tetanus vaccine, there are no conceivable porphyrinogenic effects.
Chemical description
Diphtheria Toxoid, Tetanus Toxoid, Pertussis Toxoid and inactivated poliovirus (type 1,2 and 3) (DTP-IPV)
Therapeutic characteristics
The DTP-IPV vaccine is indicated for active immunization against diphtheria, tetanus, pertussis and poliomyelitis both for primary immunization and for following booster doses. It is administered by intramuscular injections.
Metabolism and pharmacokinetics
The DTP-IPV vaccine is not metabolized by the cytochrome P450 system.
Similar drugs
References
| # | Citation details | PMID |
|---|---|---|
| * | Government bodies | |
| 1. | Norwegian Institute of Public Health. Vaksinasjonsveilederen. www.fhi.no (updated 13.10.2015).
|
|
| * | Summary of Product Characteristics | |
| 2. | The electronic Medicines Compendium (emc). Summary of Product Characteristics (SPC). Tetravac. (Last edition: 30.06 2014).
|
|
Tradenames
Boostrix 
Boostrix · Infanrix IPV · Tetravac · Triaxis Polio 
Boostrix · Infanrix-ipv · Tetraxim · Triaxis Polio 
Adacel Polio · Boostrix · Infanrix ipv · Tetraxim 
Adacel Polio · Boostrix · Tetraxim 
Adacel-Polio · Boostrix · Infanrix DTPa-IPV · Tetravac 
Boostrix · Infanrix-IPV vaccine · Repevax 
Boostrix · Repevax · Tetravac 
Boostrix · Repevax · Tetravac 
Adacel Polio · Boostrix · Infanrix-IPV · Pentaxim · Tetraxim 
Boostrix · Infanrix-ipv · Tetravac · Triaxis Polio 
Boostrix · Repevax · Tetravac 
Boostrix · Infanrix-Polio · Repevax · Tetravac 
Boostrix · Infanrix Polio · Tetraxim 
Boostrix · Infanrix polio · Tetraxim 
Infanrix Polio · Tetraxim 
Tetraxim 
Adacel Polio · Boostrix 
Vaccines